Whittier Trust »

Keros Therapeutics shares owned by Whittier Trust

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Whittier Trust from 13F filings

Historical chart of Whittier Trust investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by Whittier Trust consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by Whittier Trust

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.2k 200 15.94

More positions owned by Whittier Trust

Nvidia Corporation common (NVDA)
Microsoft Corp common (MSFT)
Apple common (AAPL)
Alphabet common (GOOG)
Amazon common (AMZN)
Ishares Tr common (IVV)
Spdr S&p 500 Etf Tr common (SPY)
Broadcom common (AVGO)
Jpmorgan Chase & Co. common (JPM)
Meta Platforms common (META)
Visa common (V)
Ishares Tr common (IJH)
Eli Lilly & Co common (LLY)
Berkshire Hathaway Inc Del common (BRK.B)
Servicenow common (NOW)

View all positions for Whittier Trust

Top funds holding Keros Therapeutics

ADAR1 Capital Management
Vanguard Group
BlackRock
Madison Avenue Partners
Western Standard
Nantahala Capital Management
Tang Capital Management
D. E. Shaw & Co
Goldman Sachs Group
State Street Corporation
OrbiMed Advisors
Morgan Stanley
Alkeon Capital Management
Logos Global Management
Geode Capital Management

View all funds holding Keros Therapeutics